Valuation: The Cooper Companies, Inc.

Market Cap 14.26B 12.46B 11.5B 10.6B 19.97B 1,373B 20.42B 137B 54.05B 672B 53.54B 52.37B 2,315B P/E 2026 *
35.9x
P/E 2027 * 19.9x
Enterprise Value 16.56B 14.47B 13.35B 12.31B 23.2B 1,595B 23.71B 160B 62.77B 781B 62.18B 60.82B 2,688B EV / Sales 2026 *
3.85x
EV / Sales 2027 * 3.56x
Free-Float
88.96%
Yield 2026 *
-
Yield 2027 * -
1 day-1.52%
1 week+1.56%
Current month+0.13%
1 month+10.38%
3 months+2.49%
6 months-10.92%
Current year-12.39%
1 week 68.37
Extreme 68.37
73.94
1 month 64.96
Extreme 64.965
74.45
Current year 58.89
Extreme 58.89
85.04
1 year 58.89
Extreme 58.89
89.83
3 years 58.89
Extreme 58.89
112.38
5 years 58.89
Extreme 58.89
115.9
10 years 39.68
Extreme 39.6833
115.9
Manager TitleAgeSince
Chief Executive Officer 56 01/05/2018
Director of Finance/CFO 47 01/05/2018
Chief Operating Officer 61 01/11/2013
Director TitleAgeSince
Director/Board Member 56 01/05/2018
Chairman 79 23/03/2021
Chairman 62 02/01/2026
Date Insider Type Main position Quantity % Market Cap.
01/07/26 Free

Director

2,814 0.0014%
01/04/26 Fiscal year

Director

9,879 0.0051%
01/04/26 Fiscal year

Director

11,087 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
-1.55%+1.56%-1.99%-27.10% 14.26B
-1.65%-2.74%-31.74%-4.79% 89.15B
-0.42%+4.15%-18.63%-21.92% 34.35B
+0.67%-1.60% - - 9.63B
-0.65%-3.19%-32.98%+500.00% 1.89B
-3.93%+4.46%-29.24%-65.46% 1.51B
-6.82%-10.67%+12.79%-9.46% 855M
-3.85%+0.87%-36.71%-25.50% 893M
-2.26%+2.06%+47.64%-31.38% 788M
-1.37%-8.66% - - 694M
Average -2.15%+0.68%-11.36%+39.30% 15.4B
Weighted average by Cap. -1.28%+0.48%-24.97%-5.38%

Financials

2026 *2027 *
Net sales 4.31B 3.76B 3.47B 3.2B 6.03B 415B 6.17B 41.51B 16.33B 203B 16.17B 15.82B 699B 4.52B 3.95B 3.64B 3.36B 6.33B 435B 6.47B 43.54B 17.12B 213B 16.96B 16.59B 733B
Net income 382M 334M 308M 284M 536M 36.83B 548M 3.69B 1.45B 18.04B 1.44B 1.4B 62.1B 657M 574M 530M 488M 920M 63.25B 941M 6.33B 2.49B 30.98B 2.47B 2.41B 107B
Net Debt 2.3B 2.01B 1.86B 1.71B 3.22B 222B 3.3B 22.18B 8.73B 109B 8.64B 8.45B 374B 1.83B 1.6B 1.47B 1.36B 2.56B 176B 2.62B 17.61B 6.93B 86.16B 6.86B 6.71B 297B
Logo The Cooper Companies, Inc.
The Cooper Companies, Inc. is a medical device company. The Company's segments include CooperVision and CooperSurgical. The CooperVision segment is engaged in developing, manufacturing and marketing a broad range of products for contact lens wearers, featuring advanced materials and optics. Its daily disposable silicone hydrogel contact lens products include MyDay daily disposable, MyDay daily disposable toric, MyDay daily disposable multifocal, and MyDay Energys. The CooperSurgical segment provides a portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. Its brands include ALLY II UPS, Advincula Delineator, Apple-Hunt Secondary Cannula, Bakri Postpartum Balloon, California Cryobank, Carter-Thomason, Cell Care, Cells for Life, Coda, Cord Blood Registry, Core Cryolab, Donor Egg Bank USA, ER-Complete, Embryo Options, and Endosee.
Employees
15,000
Date Price Change Volume
17/07/26 $71.80 -1.79% 498,882
16/07/26 $73.10 +3.54% 1,896,293
15/07/26 $70.60 +3.05% 1,945,644
14/07/26 $68.51 -3.94% 2,191,677
13/07/26 $71.32 +0.88% 1,723,481
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
73.10USD
Average target price
81.69USD
Spread / Average Target
+11.75%

Quarterly revenue - Rate of surprise